These strengths have led to triple-digit growth this year 2010. ‘Our innovative group of analytical tools, in conjunction with a commitment to provide the right answers to clients and build collaborative human relationships with Blue programs has been highly effective,’ stated Joel Portice, Intelimedix CEO and president. ‘We will continue steadily to offer best-in-course solutions that improve client efficiency and capability to respond to ongoing adjustments in the healthcare sector quickly.’..All privileges reserved. Neither of the parties endorse or suggest any commercial products, services, or equipment.. Calbiotech awarded a SBIR contract to develop analyte particular reagents for the analysis of Dengue virus Calbiotech, Inc. Announced today that it’s been awarded a Small Business Innovative Research Stage I agreement by the U.S. Army Medical Study and Material command. Under terms of the agreement, Calbiotech will establish analyte particular reagents for the medical diagnosis of Dengue virus. Dengue virus is a mosquito-born flavivirus that represents a major threat to armed service forces deployed to tropical regions of the world.